Summit Therapeutics plc Stock
Your prediction
Pros and Cons of Summit Therapeutics plc in the next few years
Pros
Cons
Performance of Summit Therapeutics plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Summit Therapeutics plc | - | - | - | - | - | - | - |
Proteome Sciences | - | 0.000% | 0.000% | 11.111% | 6.667% | -57.895% | 185.714% |
Oxford BioMedica PLC | 2.660% | 4.891% | 73.874% | -13.839% | 58.197% | -67.009% | -50.000% |
Sareum Holdings plc | -4.200% | -0.725% | 76.774% | -81.486% | -55.447% | -80.429% | - |
News
Why Summit Therapeutics Stock Crushed the Market This Week
One exceptional stock in the healthcare sector this trading week was Summit Therapeutics (NASDAQ: SMMT). Buoyed by encouraging news from the lab, the company got an additional boost on Monday with
Why Top AI Stock C3.ai Tumbled on Tuesday
One of the leading artificial intelligence (AI) stocks on the market was left far behind by investors on Tuesday. C3.ai (NYSE: AI) saw its share price crumble by almost 8% on the back of comments
Nvidia CEO Jensen Huang Encourages Countries to Build AI Infrastructure "As Fast as You Can" at Recent Summit. Time to Buy the AI Stock Hand Over Fist?
Nvidia (NASDAQ: NVDA) founder and CEO Jensen Huang recently participated in a fireside chat at the World Governments Summit in Dubai that was attended by delegates from 150 countries.
In a